Your browser doesn't support javascript.
loading
Evaluating the value proposition for improving vaccine thermostability to increase vaccine impact in low and middle-income countries.
Karp, Christopher L; Lans, Deborah; Esparza, José; Edson, Eleanore B; Owen, Katey E; Wilson, Christopher B; Heaton, Penny M; Levine, Orin S; Rao, Raja.
Afiliação
  • Karp CL; Discovery & Translational Sciences, The Bill & Melinda Gates Foundation, Seattle, WA, USA. Electronic address: chris.karp@gatesfoundation.org.
  • Lans D; Discovery & Translational Sciences, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Esparza J; Discovery & Translational Sciences, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Edson EB; Discovery & Translational Sciences, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Owen KE; Vaccine Development, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Wilson CB; Discovery & Translational Sciences, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Heaton PM; Vaccine Development, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Levine OS; Vaccine Delivery, Global Health, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Rao R; Vaccine Delivery, Global Health, The Bill & Melinda Gates Foundation, Seattle, WA, USA.
Vaccine ; 33(30): 3471-9, 2015 Jul 09.
Article em En | MEDLINE | ID: mdl-26055297
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Países em Desenvolvimento / Estabilidade de Medicamentos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Países em Desenvolvimento / Estabilidade de Medicamentos Idioma: En Ano de publicação: 2015 Tipo de documento: Article